ArticleData in brief2025
Seahorse-assessed metabolic data, CAM assay data and aspect ratio data of tenocyte in vitro cultures treated with insulin-like growth factor-1 (IGF-1), with platelet-derived growth factor-BB (PDGF-BB) or with IGF-1 and PDGF-BB simultaneously.
Article in Data in brief, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
As tendon rupture repair still implies problematic outcomes for the patients, such as re-rupture or adhesion formation to the surrounding tissue, restricting the capability for full loading or the range of motion, novel approaches are welcome and many research groups are working on the optimization of tendon repair. For example, growth factor delivery to the ruptured tendon may support the natural healing by accentuating growth factor dynamics that otherwise occur naturally. We have therefore tested insulin-like growth factor-1 (IGF-1) and platelet-derived growth factor-BB (PDGF-BB) or both mixed together under in vitro conditions, supplementing the growth factors to cell culture medium of rabbit Achilles tenocytes and rabbit adipose-derived stem cells. We have assessed the effects on the cell morphology and provide aspect ratio data, as well as metabolic data determined by Seahorse experiments, and finally CAM assay data referring to several angiogenic readouts, respectively.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.